Company intelligence / Profile preview

Qingdao Tianhe Pharmaceutical

Jinan, Shandong, China

Ownership: Private
Development stage: Other

Overview

Qilu Tianhe Pharmaceutical specializes in developing and manufacturing generic drugs and injectable formulations. It has achieved international regulatory approvals for several products, including exports to the US, EU, and Japan. Notably, its carmofur product targeting thymidylate synthase is approved for colorectal cancer. The company also manufactures piperacillin + tazobactam injectables exported globally.

Therapeutic areas: Infectious DiseasesOncology
Modalities: Small molecule drugInjectable drugs
Industry: Biotech

Beyond the preview

Go deeper on Qingdao Tianhe Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingdao Tianhe Pharmaceutical.

Explore the full profile